
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
NOVN | Switzerland | CHF | Delayed | |
NOVNz | BATS Europe | CHF | Delayed | |
NVS | NYSE | USD | Real-time | |
NVSEF | OTC Markets | USD | Delayed | |
0QLR | London | CHF | Real-time | |
NVSN | Mexico | MXN | Delayed | |
NOVZn | Frankfurt | EUR | Delayed |
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Name | Age | Since | Title |
---|---|---|---|
Joerg Reinhardt | 66 | 1999 | Independent Non-Executive Chairman |
Daniel L. Vasella | 69 | 1996 | Honorary Chairman |
William Thomas Winters | 61 | 2013 | Independent Non-Executive Director |
Charles L. Sawyers | 63 | 2013 | Independent Non-Executive Director |
Nancy C. Andrews | 64 | 2015 | Independent Non-Executive Director |
Bridgette P. Heller | 61 | 2020 | Independent Non-Executive Director |
François Adrianus van Houten | 62 | 2017 | Independent Non-Executive Director |
Simon E. Moroney | 63 | 2020 | Independent Vice Chairman of the Board |
Ana de Pro Gonzalo | - | 2022 | Director |
Daniel Hochstrasser | - | 2022 | Independent Director |
Andreas von Planta | 67 | 2006 | Independent Non-Executive Director |
Ton Buechner | 57 | 2016 | Independent Non-Executive Director |
Elizabeth Doherty | 65 | 2016 | Independent Non-Executive Director |
Patrice Bula | 66 | 2019 | Lead Independent Director |
Sidonie Golombowski-Daffner | - | - | Chairperson & President of Advanced Accelerator Applications |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review